GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (GREY:PTKMF) » Definitions » Price-to-Owner-Earnings

PT Kimia Farma Tbk (PT Kimia Farma Tbk) Price-to-Owner-Earnings : (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is PT Kimia Farma Tbk Price-to-Owner-Earnings?

As of today (2024-06-19), PT Kimia Farma Tbk's share price is $0.00. PT Kimia Farma Tbk does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for PT Kimia Farma Tbk's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of PT Kimia Farma Tbk was 1730.28. The lowest was 13.89. And the median was 86.15.


PTKMF's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 11.4
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-19), PT Kimia Farma Tbk's share price is $0.00. PT Kimia Farma Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Therefore, PT Kimia Farma Tbk's PE Ratio for today is N/A.

As of today (2024-06-19), PT Kimia Farma Tbk's share price is $0.00. PT Kimia Farma Tbk's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, PT Kimia Farma Tbk's PE Ratio without NRI for today is N/A.

During the past 13 years, PT Kimia Farma Tbk's highest PE Ratio without NRI was 1780.09. The lowest was 12.40. And the median was 35.35.


PT Kimia Farma Tbk Price-to-Owner-Earnings Historical Data

The historical data trend for PT Kimia Farma Tbk's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Price-to-Owner-Earnings Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Kimia Farma Tbk Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PT Kimia Farma Tbk's Price-to-Owner-Earnings

For the Medical Distribution subindustry, PT Kimia Farma Tbk's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kimia Farma Tbk's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where PT Kimia Farma Tbk's Price-to-Owner-Earnings falls into.



PT Kimia Farma Tbk Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

PT Kimia Farma Tbk's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Kimia Farma Tbk  (GREY:PTKMF) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


PT Kimia Farma Tbk Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kimia Farma Tbk (PT Kimia Farma Tbk) Business Description

Traded in Other Exchanges
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.

PT Kimia Farma Tbk (PT Kimia Farma Tbk) Headlines

No Headlines